StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report published on Sunday. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Global Cord Blood stock opened at $1.26 on Friday. The stock’s 50 day moving average is $1.62 and its 200 day moving average is $1.38. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The firm has a market cap of $152.55 million, a P/E ratio of 1.96 and a beta of 0.16.
About Global Cord Blood
Featured Articles
- Five stocks we like better than Global Cord Blood
- How to Most Effectively Use the MarketBeat Earnings Screener
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- How Investors Can Find the Best Cheap Dividend Stocks
- AMD Gains Momentum With AI: Can It Beat Expectations?
- How to Calculate Inflation Rate
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.